Search Results

There are 2978 results for: content related to: A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

  1. Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 1, February 2015, Pages: 98–103, Y. Akamine, M. Miura, N. Yasui-Furukori, I. Ieiri and T. Uno

    Version of Record online : 27 SEP 2014, DOI: 10.1111/jcpt.12213

  2. Time-Dependent Interaction Between Lopinavir/Ritonavir and Fexofenadine

    The Journal of Clinical Pharmacology

    Volume 46, Issue 7, July 2006, Pages: 758–767, P. G. Rolf, Dr van Heeswijk, Mr Marc Bourbeau, Ms Pearl Campbell, Ms Isabelle Seguin, Mr Bobby M. Chauhan, Dr Brian C. Foster and Dr D. William Cameron

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006288733

  3. Enantioselective uptake of fexofenadine by Caco-2 cells as model intestinal epithelial cells

    Journal of Pharmacy and Pharmacology

    Volume 65, Issue 1, January 2013, Pages: 22–29, Kohei Togami, Yuka Tosaki, Sumio Chono, Kazuhiro Morimoto, Masataka Hayasaka and Hitoshi Tada

    Version of Record online : 25 OCT 2012, DOI: 10.1111/j.2042-7158.2012.01569.x

  4. Evaluation of First-Pass Cytochrome P4503A (CYP3A) and P-Glycoprotein Activities Using Alfentanil and Fexofenadine in Combination

    The Journal of Clinical Pharmacology

    Volume 45, Issue 1, January 2005, Pages: 79–88, Dr Evan D. Kharasch, Ms Alysa Walker, Ms Christine Hoffer and Ms Pamela Sheffels

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004269705

  5. Influence of P-glycoprotein on the disposition of fexofenadine and its enantiomers

    Journal of Pharmacy and Pharmacology

    Volume 69, Issue 3, March 2017, Pages: 274–284, Fei Li, Karyn D. Howard and Michael J. Myers

    Version of Record online : 16 JAN 2017, DOI: 10.1111/jphp.12687

  6. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis – a pooled analysis of three studies

    Pediatric Allergy and Immunology

    Volume 15, Issue 3, June 2004, Pages: 253–260, Eli O. Meltzer, Pierre Scheinmann, Jose E. Rosado Pinto, Claus Bachert, Gunilla Hedlin, Ulrich Wahn, Albert F. Finn Jr and Erik Ruuth

    Version of Record online : 22 JUN 2004, DOI: 10.1111/j.1399-3038.2004.00167.x

  7. The systemic safety of fexofenadine HCl

    Clinical & Experimental Allergy

    Volume 29, Issue S3, July 1999, Pages: 163–170, J. Mason, R. Reynolds and N. Rao

    Version of Record online : 10 SEP 2009, DOI: 10.1046/j.1365-2222.1999.0290s3163.x

  8. Probenecid, but Not Cystic Fibrosis, Alters the Total and Renal Clearance of Fexofenadine

    The Journal of Clinical Pharmacology

    Volume 48, Issue 8, August 2008, Pages: 957–965, Dr. Shanshan Liu, Paul M. Beringer, Dr. Levita Hidayat, Dr. Adupa P. Rao, Dr. Stan Louie, Dr. Gilbert J. Burckart and Dr. Bertrand Shapiro

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008319707

  9. Quantification of the transporter substrate fexofenadine in cell lysates by liquid chromatography/tandem mass spectrometry

    Rapid Communications in Mass Spectrometry

    Volume 25, Issue 16, 30 August 2011, Pages: 2361–2366, Colleen A. Flynn, Yazen Alnouti and Gregory A. Reed

    Version of Record online : 18 JUL 2011, DOI: 10.1002/rcm.5111

  10. Effect of Piperine, a Major Component of Black Pepper, on the Intestinal Absorption of Fexofenadine and Its Implication on Food–Drug Interaction

    Journal of Food Science

    Volume 75, Issue 3, April 2010, Pages: H93–H96, Ming-Ji Jin and Hyo-Kyung Han

    Version of Record online : 11 MAR 2010, DOI: 10.1111/j.1750-3841.2010.01542.x

  11. The effect of rifampin administration on the disposition of fexofenadine

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 3, March 2001, Pages: 114–121, Mitchell A. Hamman, Melissa A. Bruce, Barbara D. Haehner-Daniels and Stephen D. Hall

    Version of Record online : 18 MAR 2001, DOI: 10.1067/mcp.2001.113697

  12. You have free access to this content
    The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers

    British Journal of Clinical Pharmacology

    Volume 65, Issue 5, May 2008, Pages: 693–700, Tomonori Tateishi, Masatomo Miura, Toshio Suzuki and Tsukasa Uno

    Version of Record online : 20 FEB 2008, DOI: 10.1111/j.1365-2125.2008.03116.x

  13. Pharmacokinetics of fexofenadine enantiomers in healthy subjects

    Chirality

    Volume 19, Issue 3, March 2007, Pages: 223–227, Masatomo Miura, Tsukasa Uno, Tomonori Tateishi and Toshio Suzuki

    Version of Record online : 17 JAN 2007, DOI: 10.1002/chir.20370

  14. You have free access to this content
    Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers

    British Journal of Clinical Pharmacology

    Volume 73, Issue 3, March 2012, Pages: 478–481, Yumiko Akamine, Masatomo Miura, Norio Yasui-Furukori, Midori Kojima and Tsukasa Uno

    Version of Record online : 13 FEB 2012, DOI: 10.1111/j.1365-2125.2011.04106.x

  15. Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine

    Clinical Pharmacology & Therapeutics

    Volume 74, Issue 5, November 2003, Pages: 423–436, Christer Tannergren, Niclas Petri, Lars Knutson, Mikael Hedeland, Ulf Bondesson and Hans Lennernäs

    Version of Record online : 27 NOV 2003, DOI: 10.1016/S0009-9236(03)00238-8

  16. You have free access to this content
    Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil

    British Journal of Clinical Pharmacology

    Volume 67, Issue 5, May 2009, Pages: 535–540, Takashi Sakugawa, Masatomo Miura, Nobuo Hokama, Toshio Suzuki, Tomonori Tateishi and Tsukasa Uno

    Version of Record online : 23 FEB 2009, DOI: 10.1111/j.1365-2125.2009.03396.x

  17. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers

    Clinical Pharmacology & Therapeutics

    Volume 64, Issue 6, December 1998, Pages: 612–621, Tanya Russell, Maxine Stoltz and Scott Weir

    Version of Record online : 3 DEC 1998, DOI: 10.1016/S0009-9236(98)90052-2

  18. Dose proportionality and comparison of single and multiple dose pharmacokinetics of fexofenadine (MDL 16 455) and its enantiomers in healthy male volunteers

    Biopharmaceutics & Drug Disposition

    Volume 19, Issue 7, October 1998, Pages: 455–463, Doris K. Robbins, Mark A. Castles, David J. Pack, Vijay O. Bhargava and Scott J. Weir

    Version of Record online : 21 DEC 1998, DOI: 10.1002/(SICI)1099-081X(199810)19:7<455::AID-BDD130>3.0.CO;2-W

  19. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis

    Clinical & Experimental Allergy

    Volume 30, Issue 6, June 2000, Pages: 891–899, Van Cauwenberge, Juniper and THE STAR STUDY INVESTIGATING GROUP

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2222.2000.00914.x

  20. Central Effects of Fexofenadine and Cetirizine: Measurement of Psychomotor Performance, Subjective Sleepiness, and Brain Histamine H1-Receptor Occupancy Using 11C-Doxepin Positron Emission Tomography

    The Journal of Clinical Pharmacology

    Volume 44, Issue 8, August 2004, Pages: 890–900, Dr Manabu Tashiro, Dr Yumiko Sakurada, Dr Kentaro Iwabuchi, Dr Hideki Mochizuki, Motohisa Kato, Mariko Aoki, Dr Yoshihito Funaki, Dr Masatoshi Itoh, Dr Ren Iwata, Dr Dean F. Wong and Dr Kazuhiko Yanai

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004267590